Dephosphorization of Iron Ore through Bioleaching

Phosphorus, as phosphate, is frequently found as a constituent of many of the world iron resources. Phosphorus is an extremely harmful element found in iron ore used as a raw material in the steelmaking process because it will affect the quality of iron and steel products. Allowable phosphorus concentration in high quality steel is usually less than 0.08%. Dephosphorization of iron ore has been studied for a long time. Although there are described physical beneficiation and chemical leaching processes, involving inorganic acids, to reduce phosphorus content of iron ores, these processes have several limitations such as poor recovery, require high energy quantity, capital costs and cause environmental pollution. Use of microorganisms in leaching of mineral ores is gaining importance due to the implementation of stricter environmental rules. Microbes convert metal compounds into their water soluble forms and are biocatalysts of leaching processes. Biotechnology is considered as an eco-friendly, promising, and revolutionary solution to these problems. Microorganisms play a critical role in natural phosphorus cycle and the process of phosphate solubilization by microorganisms has been known for many years. This study was performed to analyze the possibility of using bioleaching as a process for the dephosphorization of an iron ore from Northeast of Portugal. For bioleaching, Acidithiobacillus ferrooxidans bacterium were used. For this study two experiments were done with different conditions, which lasts 6 weeks for first experiment and 5 weeks for second experiment. From the result of these preliminary studies, it was observed that for first experiment 6.2 % and for second experiment 3.7 % of phosphorus was removed from iron ore.

Haemocompatibility of iron oxide nanoparticles synthesized for theranostic applications: a high-sensitivity microfluidic tool

The poor heating efficiency of the most reported magnetic nanoparticles (MNPs), allied to the lack of comprehensive biocompatibility and haemodynamic studies, hampers the spread of multifunctional nanoparticles as the next generation of therapeutic bio-agents in medicine. The present work reports the synthesis and characterization, with special focus on biological/toxicological compatibility, of superparamagnetic nanoparticles with diameter around 18 nm, suitable for theranostic applications (i.e. simultaneous diagnosis and therapy of cancer). Envisioning more insights into the complex nanoparticle-red blood cells (RBCs) membrane interaction, the deformability of the human RBCs in contact with magnetic nanoparticles (MNPs) was assessed for the first time with a microfluidic extensional approach, and used as an indicator of haematological disorders in comparison with a conventional haematological test, i.e. the haemolysis analysis. Microfluidic results highlight the potential of this microfluidic tool over traditional haemolysis analysis, by detecting small increments in the rigidity of the blood cells, when traditional haemotoxicology analysis showed no significant alteration (haemolysis rates lower than 2 %). The detected rigidity has been predicted to be due to the wrapping of small MNPs by the bilayer membrane of the RBCs, which is directly related to MNPs size, shape and composition. The proposed microfluidic tool adds a new dimension into the field of nanomedicine, allowing to be applied as a highsensitivity technique capable of bringing a better understanding of the biological impact of nanoparticles developed for clinical applications.